Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Jonathan A. Coleman

Urology
Mskcc Surgery Group
1133 York Ave, 
New York, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
Mskcc Surgery Group
1133 York Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jonathan Coleman is an Urologist in New York, New York. Dr. Coleman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy.

His clinical research consists of co-authoring 259 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

MSKCC SURGERY GROUP
1133 York Ave, New York, NY 10065
Call: 646-888-7100
Other Locations
MSKCC SURGERY GROUP
353 E 68th St, New York, NY 10065
Call: 646-422-4300
MSKCC SURGERY GROUP
1275 York Ave, New York, NY 10065
Call: 212-639-2000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer
Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer
Enrollment Status: Recruiting
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drug: TOOKAD VTP
Study Phase: Phase 3
Phase I Study of WST11 Phototherapy for Upper Tract Urothelial Carcinoma
Phase I Study of WST11 Phototherapy for Upper Tract Urothelial Carcinoma
Enrollment Status: Completed
Publish Date: July 18, 2025
Intervention Type: Drug, Procedure
Study Drug: WST11 mediated vascular targeted phototherapy
Study Phase: Phase 1
Diagnosing Clinically Significant Prostate Cancer in African American and White Men Phase II, Randomized Clinical Trial, Multi-center, MR-Guided vs. 12-core Systematic Random Biopsy, Localized Prostate Cancer
Diagnosing Clinically Significant Prostate Cancer in African American and White Men Phase II, Randomized Clinical Trial, Multi-center, MR-Guided vs. 12-core Systematic Random Biopsy, Localized Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2025
Intervention Type: Diagnostic test, Other, Procedure
Study Phase: Not Applicable
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
Enrollment Status: Completed
Publish Date: February 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Minimally Invasive Treatment of Localized Intermediate Risk Prostate Cancer.
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Minimally Invasive Treatment of Localized Intermediate Risk Prostate Cancer.
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2024
Intervention Type: Drug
Study Drug: TOOKAD Soluble
Study Phase: Phase 2
View 4 Less Clinical Trials

259 Total Publications

Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A).
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A).
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2025
View All 259 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul S. Russo
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul S. Russo
Urology

Mskcc Surgery Group

353 E 68th St, 
New York, NY 
 (0.4 miles away)
646-422-4300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Paul Russo is an Urologist in New York, New York. Dr. Russo is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Abraham A. Hakimi
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Abraham A. Hakimi
Urology

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (0.3 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Abraham Hakimi is an Urologist in New York, New York. Dr. Hakimi is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ketan K. Badani
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ketan K. Badani
Urology

Icahn School Of Medicine At Mount Sinai

2510 30th Ave, 
Long Island City, NY 
 (1.9 miles away)
718-932-1000
Languages Spoken:
English
See accepted insurances

Ketan Badani is an Urologist in Long Island City, New York. Dr. Badani is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Coleman's expertise for a condition
ConditionClose
  • Elite
  • Chromophobe Renal Cell Carcinoma
    Dr. Coleman is
    Elite
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Nephrectomy
    Dr. Coleman is
    Elite
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Prostate Cancer
    Dr. Coleman is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Renal Cell Carcinoma (RCC)
    Dr. Coleman is
    Elite
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Upper Tract Urothelial Carcinoma (UTUC)
    Dr. Coleman is
    Elite
    . Learn about Upper Tract Urothelial Carcinoma (UTUC).
    See more Upper Tract Urothelial Carcinoma (UTUC) experts
  • Urothelial Cancer
    Dr. Coleman is
    Elite
    . Learn about Urothelial Cancer.
    See more Urothelial Cancer experts
  • Distinguished
  • Bladder Cancer
    Dr. Coleman is
    Distinguished
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Clear Cell Sarcoma
    Dr. Coleman is
    Distinguished
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Familial Prostate Cancer
    Dr. Coleman is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Familial Wilms Tumor 2
    Dr. Coleman is
    Distinguished
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Obstructive Uropathy
    Dr. Coleman is
    Distinguished
    . Learn about Obstructive Uropathy.
    See more Obstructive Uropathy experts
  • Prostatectomy
    Dr. Coleman is
    Distinguished
    . Learn about Prostatectomy.
    See more Prostatectomy experts
View All 9 Distinguished Conditions
  • Advanced
  • Bilateral Hydronephrosis
    Dr. Coleman is
    Advanced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Cystectomy
    Dr. Coleman is
    Advanced
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Empyema
    Dr. Coleman is
    Advanced
    . Learn about Empyema.
    See more Empyema experts
  • Hydronephrosis
    Dr. Coleman is
    Advanced
    . Learn about Hydronephrosis.
    See more Hydronephrosis experts
  • Muscle Invasive Bladder Cancer
    Dr. Coleman is
    Advanced
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Coleman is
    Advanced
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
View All 9 Advanced Conditions
  • Experienced
  • Bladder Outlet Obstruction
    Dr. Coleman is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Boils
    Dr. Coleman is
    Experienced
    . Learn about Boils.
    See more Boils experts
  • Carbuncle
    Dr. Coleman is
    Experienced
    . Learn about Carbuncle.
    See more Carbuncle experts
  • Chylous Ascites
    Dr. Coleman is
    Experienced
    . Learn about Chylous Ascites.
    See more Chylous Ascites experts
  • Congenital Mesoblastic Nephroma
    Dr. Coleman is
    Experienced
    . Learn about Congenital Mesoblastic Nephroma.
    See more Congenital Mesoblastic Nephroma experts
  • Endoscopy
    Dr. Coleman is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved